Log in
Log in
E-mail
Password

Show password
Remember
Forgot password ?
Become a member for free
Sign up
Become a member for free
Sign up
New member
Sign up for FREE
New customer
Discover our services
  1. Homepage
  2. Equities
  3. United States
  4. Nyse
  5. Pfizer, Inc.
  6. News
  7. Summary
    PFE   US7170811035

PFIZER, INC.

(PFE)
  Report
Delayed Nyse  -  05/20 04:03:19 pm EDT
52.47 USD   +3.59%
04:31pWall Street ends mixed after punishing week
RE
01:16pRite Aid to Start Administering Pfizer's Booster Shot to Chidren Ages 5 to 11
MT
11:07aPfizer Enters Deal to Sell COVID-19 Drug Paxlovid to Switzerland
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

GSK AND PFIZER HOLD OUT FOR £60BN BID FOR CONSUMER HEALTH UNIT - FT

01/16/2022 | 04:33pm EDT
share with twitter
share with LinkedIn
share with facebook

GSK AND PFIZER HOLD OUT FOR £60BN BID FOR CONSUMER HEALTH UNIT - FT


© Reuters 2022
All news about PFIZER, INC.
04:31pWall Street ends mixed after punishing week
RE
01:16pRite Aid to Start Administering Pfizer's Booster Shot to Chidren Ages 5 to 11
MT
11:07aPfizer Enters Deal to Sell COVID-19 Drug Paxlovid to Switzerland
MT
10:54aPfizer's Xeljanz Recommended By European Medicines Agency Committee to Treat Ankylosing..
MT
09:39aSwitzerland Secures Order for Pfizer's Antiviral COVID-19 Drug Paxlovid
MT
06:28aEU Member States Seek Changes To Supply Contracts For COVID-19 Jabs Amid Declining Dema..
MT
05/19US Health Agency Approves Pfizer-BioNTech's COVID-19 Booster Jab For Children
MT
05/19CDC urges Pfizer booster for children ages 5 to 11
AQ
05/19EU health regulator backs using AstraZeneca COVID shot as booster
RE
05/19Thinking about trading options or stock in Tesla, Microsoft, Walt Disney, NVIDIA, or Pf..
PR
More news
Analyst Recommendations on PFIZER, INC.
More recommendations
Financials (USD)
Sales 2022 104 B - -
Net income 2022 35 662 M - -
Net cash 2022 10 478 M - -
P/E ratio 2022 8,45x
Yield 2022 3,20%
Capitalization 294 B 294 B -
EV / Sales 2022 2,73x
EV / Sales 2023 3,58x
Nbr of Employees 79 000
Free-Float 58,2%
Chart PFIZER, INC.
Duration : Period :
Pfizer, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends PFIZER, INC.
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 23
Last Close Price 50,65 $
Average target price 57,79 $
Spread / Average Target 14,1%
EPS Revisions
Managers and Directors
Albert Bourla Chairman, Chief Executive & Operating Officer
David M. Denton Chief Financial Officer & Executive Vice President
Mikael Dolsten Executive VP, President-Research & Development
Lidia L. Fonseca Executive VP, Chief Digital & Technology Officer
Aida Habtezion Chief Medical Officer
Sector and Competitors
1st jan.Capi. (M$)
PFIZER, INC.-11.14%284 192
JOHNSON & JOHNSON2.59%457 706
ABBVIE INC.12.05%268 106
ROCHE HOLDING AG-16.41%265 188
ELI LILLY AND COMPANY3.64%257 689
NOVO NORDISK A/S-0.56%236 239